Search results
Cyclist continues to defy Parkinson’s disease with planned race up Haleakala | Honolulu...
Honolulu Star-Advertiser· 5 days agoMore than 12 years after his diagnosis, Mokuahi is set to bike 36 miles and 10,000 feet up to the...
Annovis Bio (NYSE: ANVS) Announces Results of Recent Alzheimer's Study
Digital Journal· 2 days agoPRESS RELEASE Published June 12, 2024 InvestorBrandNetwork Annovis Bio (NYSE: ANVS) , a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative ...
Analysts brand Huntington's trial 'underwhelming' as Sage no closer to proving dalzanemdor's...
FierceBiotech· 3 days agoThe company has lined up the NMDA receptor positive allosteric modulator for four midstage trials...
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide...
Digital Journal· 3 days ago"This new patent application covers groundbreaking advancements in a novel series of dual orexin receptor agonists targeting narcolepsy as the primary indication and neurodegenerative conditions ...
Iowa West Foundation mini-grants enable lots of little moments of joy in Council Bluffs
Southwest Iowa's daily newspaper· 1 day agoThe Healthy Living Center located at 714 S Main St. provides activities and amenities for older...
Céline Dion Took Up to 90 Milligrams of Valium During Health Struggles: 'It Could Have Been Fatal'...
People via Yahoo News· 3 days agoHaving Dion speak out publicly about her own experience with the autoimmune and neurological...
Virginia Democrat robbed of voice by 'Parkinson's on steroids' is first to use text-to-speech device...
Business Insider· 5 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
SAGE's Huntington's Disease Study Meets Primary Endpoint
Zacks via Yahoo Finance· 2 days agoThe phase II SURVEYOR study evaluating SAGE's dalzanemdor as a potential treatment for patients with...
State officials, AARP urge older adults to be on guard against financial scams
Maryland Matters via Yahoo News· 4 days agoLast year, Maryland had the fifth-highest rate of reported impostor scams in the nation. The post...
Yumanity Therapeutics (NASDAQ:YMTX) Trading Down 3%
ETF DAILY NEWS· 5 days agoYumanity Therapeutics, Inc. (NASDAQ:YMTX – Get Free Report) was down 3% during trading on Friday . The stock traded as low as $0.44 and last traded at $0.47. Approximately 126,269 shares traded ...
